Welcome to our dedicated page for Lifeway Food SEC filings (Ticker: LWAY), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Lifeway Foods turns milk into gut-healthy kefir, but its SEC disclosures are where you’ll spot the numbers behind every probiotic bottle. Investors often ask where to locate milk-price sensitivity, how much revenue the ProBugs kids line contributes, or whether new distribution in the UAE affects margins. Those answers sit inside dense 10-Ks and 10-Qs—documents that can stretch past 300 pages.
Stock Titan’s AI trims the reading list. Open the Lifeway Foods quarterly earnings report 10-Q filing and our algorithm highlights same-store sales growth, inventory levels, and commodity cost hedges. Need Lifeway Foods insider trading Form 4 transactions? Real-time alerts surface every executive stock move, giving you the complete Lifeway Foods Form 4 insider transactions real-time feed without sorting through EDGAR. You’ll also find plain-language cards that make Lifeway Foods SEC filings explained simply, from Lifeway Foods annual report 10-K simplified to Lifeway Foods 8-K material events explained.
Why dig this deep? Filings reveal how Lifeway manages dairy supply contracts, tracks live-culture quality controls, and prices its expanding international lineup. In the proxy you’ll see Lifeway Foods proxy statement executive compensation that links bonuses to sales of kefir and cheese, while our dashboard delivers Lifeway Foods earnings report filing analysis that compares gut-health SKUs quarter over quarter. For advanced monitoring, set watchlists to flag Lifeway Foods executive stock transactions Form 4 before product launches. From milk procurement footnotes to distribution-channel breakdowns, our AI turns regulatory text into actionable context so you can focus on the trends—not the paperwork.
Edward Smolyansky, a director of Lifeway Foods, Inc. (LWAY), reported open-market sales of common stock on 09/23/2025 and 09/24/2025. He sold 6,357 shares on 09/23/2025 at a weighted average price of $26.53 and 10,000 shares on 09/24/2025 at a weighted average price of $26.69, reducing his direct holdings to 1,235,285 shares. The filing also discloses multiple indirect holdings: 75,000 shares held by a family foundation, 1,233,333 shares in a trust for which he is trustee, 100,000 shares owned by his son (disclaimed), and 500,000 shares held by Smolyansky Holding LLC (partially disclaimed). The form is signed and dated 09/25/2025.
Lifeway Foods (LWAY) submitted a Form 144 disclosing a proposed sale of 10,000 shares of common stock through Citigroup Global Markets, slated for 09/24/2025, with an aggregate market value of $266,914 and 15,226,520 shares outstanding. The filing states the securities were acquired on 05/19/2023 from Ludmila Smolyansky for cash, showing an acquisition amount of 3,197,975 shares on that date. The notice also reports a recent sale: Edward Smolyansky sold 6,357 shares on 09/23/2025 for $168,653.75. The filer affirms no undisclosed material adverse information.
Form 144 notice for Lifeway Foods, Inc. (LWAY) shows a proposed sale of 6,357 shares of common stock through Citigroup Global Markets Inc. on 09/23/2025 on NASDAQ with an aggregate market value of $168,653.75. The filing reports that the securities were acquired on 05/19/2023 by purchase from Ludmila Smolyansky and that 3,197,975 shares were acquired on that date for cash. The total number of shares outstanding is listed as 15,226,520. Several issuer-identifying fields (issuer name, address, and the specific name of the person for whose account the securities are to be sold) are not provided in the visible content of this form.
Danone entities report a 22.7% stake in Lifeway Foods (3,454,756 shares) and amend their Schedule 13D to update intentions. Danone North America entered a confidentiality agreement with Lifeway on August 1, 2025 to review a potential acquisition but on September 17, 2025 determined it would no longer pursue an acquisition and notified Lifeway. Danone is now reviewing alternatives for its investment, which may include selling or holding its shares, or voting for proposals in a pending consent solicitation to replace Lifeway's board; no final decisions have been made.
Lifeway Foods reported stronger top-line and profitability in the quarter ended June 30, 2025. Net sales for the three months were $53.9 million, up 9.7% year-over-year, producing gross profit of $15.4 million (28.6% of sales) and net income of $4.249 million, or $0.28 per diluted share. For the six months, net sales were $99.99 million, net income $7.789 million, and diluted EPS $0.51.
Liquidity and balance sheet items strengthened: cash and equivalents were $21.22 million, total assets $98.27 million, and stockholders' equity $78.70 million. The company recognized a $3.407 million gain and $5.206 million proceeds from the sale of its Simple Mills investment in the six months. Lifeway increased its revolving credit commitment to $25.0 million (no borrowings outstanding) and was in compliance with covenants. In July 2025 the company purchased 224 mature dairy cows for $694 and entered a 39-month herd management agreement; accounting treatment is under evaluation.
Lifeway Foods, Inc. disclosed that it issued a press release reporting its financial results for the three and six months ended June 30, 2025, and attached that release as Exhibit 99.1 to this Form 8-K.
The company also announced estimated net sales of $26.4 million for the third quarter through August 11, 2025, which the filing states represents a 20% increase from approximately $22 million for the same period last year. The filing clarifies that the press release information is incorporated by reference and is not "filed" for Section 18 liabilities.
Danone S.A. and subsidiary Danone North America PBC filed Amendment No. 9 to their Schedule 13D on Lifeway Foods (LWAY) dated 1 Aug 2025. The group continues to own 3,454,756 common shares—22.7 % of the 15.2 million shares outstanding—held directly by the U.S. unit, giving it sole voting and dispositive power; the French parent is an indirect owner.
After Lifeway rejected two takeover proposals in 2024, the issuer reopened dialogue in late June 2025. On 1 Aug 2025 both parties executed a confidentiality agreement (NDA) to allow further due-diligence on a potential acquisition. The NDA places a stand-still that bars Danone from public bids, proxy solicitations or director nominations until 15 Sep 2025, extendable by seven days if good-faith talks continue. Danone may still vote its shares. If no definitive deal is reached by the stand-still expiry, Danone presently intends to back Edward Smolyansky’s consent solicitation to replace the entire Lifeway board.
The filing stresses that no transaction is guaranteed and Danone may change its intentions.
FAQ
What is the current stock price of Lifeway Food (LWAY)?
What is the market cap of Lifeway Food (LWAY)?
